Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure

NAUnknownINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Liver Failure, Acute
Interventions
PROCEDURE

hiHep Bioartificial Liver Support System

Continuous treatment with the hiHep bioartificial liver support system for a minimum of 3 days to a maximum of 14 days. The subject's ultrafiltrated blood is circulated through 4 cartridges. The parameter is set to Circuit 1:120-200ml/min;Circuit 2:30-50ml/min;Circuit 3:200 ml/min.

PROCEDURE

Standard care for ALF

A standard of care for subjects with acute liver failure.

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Shanghai East Hospital

OTHER

NCT03084198 - Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure | Biotech Hunter | Biotech Hunter